Veradermics, Incorporated (MANE) — Financial Flexibility Index

Latest as of March 2026: -3.15x

Veradermics, Incorporated (MANE) has a Financial Flexibility Index of -3.15x as of March 2026. Free cash flow of $-21.17 Million (operating CF $-21.17 Million minus capex $0.00) represents -3% of total liabilities ($6.72 Million). Check MANE tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-3.15x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-21.17 Million
Operating CF − Capex

Total Liabilities

$6.72 Million
USD

Capital Expenditures

$0.00
USD

Veradermics, Incorporated Financial Flexibility Index (2023–2025)

Historical Financial Flexibility Index trend for Veradermics, Incorporated across 3 annual periods. For the full cash flow conversion analysis, see Veradermics, Incorporated (MANE) cash flow conversion.

Annual Financial Flexibility Index for Veradermics, Incorporated (2023–2025)

Year-by-year free cash flow to debt coverage for Veradermics, Incorporated. Explore MANE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.26x $-71.58 Million $-71.60 Million $273.63 Million ▲ +94.8%
2024 -5.02x $-23.69 Million $-23.69 Million $4.72 Million ▼ -42.6%
2023 -3.52x $-13.51 Million $-13.51 Million $3.84 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities